CLASS II ONGOING Device recall · Reported 18 Jun 2025 · FDA Enforcement Report

Azure S DR MRI SureScan, Product number W3DR01 recalled by Medtronic

Medtronic is recalling Azure S DR MRI SureScan, Product number W3DR01. The recall was initiated on 29 Apr 2025 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesSerial numbers RNJ108800G, RNJ108808G, RNJ108810G UDI-DI 00763000956004 ***Updated 10/14/25*** Scope expanded to include implanted devices, serial numbers: RNJ108803G RNJ108804G RNJ108820G
Quantity recalled6

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-1924-2025
FDA event ID
96722
Recalling firm
Medtronic, Mounds View, MN
Classification
Class II
Status
Ongoing
Recall initiated
29 Apr 2025
FDA classified
6 Jun 2025
Reported
18 Jun 2025
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Device Malfunction

Timeline

29 Apr 2025Recall initiated by company
6 Jun 2025Classified by FDA+38 days
18 Jun 2025Published in enforcement report+12 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Identified devices may experience sudden battery power failure without alarm, power supply power-on-resets, and interruption of therapy. Potential patient harms include insufficient pacing support leading to cardiac arrest, syncope, or hospitalization; or system revision (explant/replacement) leading to infection, hematoma, or temporary impairment.

Device recalls are issued when a component, software or design fault could cause the device to fail or give wrong readings. Many are corrections applied in the field rather than physical returns.

Product as listed by the FDA

Azure S DR MRI SureScan, Product number W3DR01

Where it was distributed

International distribution of the country of UK. No US distribution.

Questions about this recall

Why was it recalled?

Identified devices may experience sudden battery power failure without alarm, power supply power-on-resets, and interruption of therapy. Potential patient harms include insufficient pacing support leading to cardiac arrest, syncope, or hospitalization; or system revision (explant/replacement) leading to infection, hematoma, or temporary impairment.

Which lots are affected?

Serial numbers RNJ108800G, RNJ108808G, RNJ108810G UDI-DI 00763000956004 ***Updated 10/14/25*** Scope expanded to include implanted devices, serial numbers: RNJ108803G RNJ108804G RNJ108820G

Where was it sold?

International distribution of the country of UK. No US distribution.

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Medtronic

All 148

Other Imaging Equipment recalls

All 2,347